MarketCapTrends
TGTX

TG Therapeutics, Inc. (TGTX)

NASDAQ · Healthcare

TG Therapeutics, Inc. annual/quarterly total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • TG Therapeutics, Inc. total liabilities for the quarter ending December 31, 2025 were 415.2M, a 16.86% increase year-over-year.
  • TG Therapeutics, Inc. total liabilities for 2025 were 415.2M, a 16.86% increase from 2024.
  • TG Therapeutics, Inc. total liabilities for 2024 were 355.3M, a 110.15% increase from 2023.
  • TG Therapeutics, Inc. total liabilities for 2023 were 169.1M, a 25.26% increase from 2022.
  • TG Therapeutics, Inc. total liabilities for 2022 were 135.0M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
TG Therapeutics, Inc. Annual Total Liabilities (Millions of US $)
2025$415
2024$355
2023$169
2022$135
2021$142
2020$106
2019$124
2018$60
2017$30
2016$19
TG Therapeutics, Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$415
2024-12-31$355
2023-12-31$169
2022-12-31$135
2021-12-31$142
2020-12-31$106
2019-12-31$124
2018-12-31$60
2017-12-31$30
2016-12-31$19

TG Therapeutics, Inc. Total Liabilities — FAQ

TG Therapeutics, Inc. (TGTX) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see TGTX's total liabilities history?

The chart and table above show TG Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.